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Investigating subcellular localization of tPA and PAI-1 in the mammalian circadian clock
Tucker Hunley
ABSTRACT
Mammalian circadian rhythms are controlled by a central pacemaker located in the
suprachiasmatic nucleus (SCN) of the brain. The SCN exhibits endogenous rhythms in neuronal
activity and entrains to external stimuli, particularly light. Interestingly, phase shifts in response
to light only occur at night and the mechanisms gating phase shifting are not well characterized.
Our lab demonstrated that the extracellular protease, tissue-type plasminogen activator (tPA) and
its inhibitor, plasminogen activator inhibitor-1 (PAI-1), help gate phase shifting. Total tPA and
PAI-1 expression are rhythmic in mouse SCN. These proteins mediate different functions
depending on their exact subcellular localization. Therefore, knowing where they are located
within the SCN will clarify their actions with respect to SCN clock phase regulation. The
immortalized rat SCN2.2 cell culture exhibits rhythms in protein expression in vitro that mirror
those found in vivo and can be separated into cellular, extracellular matrix, and media fractions.
Here, we investigate tPA and PAI-1 expression using western blotting in the cellular fraction of
the SCN2.2 line over a 36-hour timecourse. Preliminary results suggest a rhythm of PAI-1 levels
inside the cell with peak expression in the early subjective night while tPA levels possibly
increase continuously. Future studies are aimed toward elucidating the subcellular localization
and temporal expression patterns of these proteins in the SCN.

INTRODUCTION
Circadian rhythms are daily 24-hour cycles of arousal and rest, as well as a multitude of
other physiological cycles, exhibited by a vast number of organisms. These oscillations manifest
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themselves in multiple ways with examples ranging from changes in gene transcription of
chlorophyll in pea plants to the triple Kai protein clock system in cyanobacteria to melatonin
regulation and synchronization of peripheral tissue subordinate clocks in mice (Foster, 2005,
Johnson, 2007, Peek et al., 2015). Few topics in biology are as ubiquitous between species and as
vital to the function and survival of each organism as the circadian rhythm.
This study focuses on the mammalian circadian clock located in an area of the
hypothalamus called the suprachiasmatic nucleus (SCN), named so because of its position
superior to the optic chiasm. Behaviors such as wakefulness, glucose metabolism, and sleep,
among other physiological functions, are all dependent on the SCN’s rhythmic control and the
body’s current stage within the cycle (Peek et al., 2015). This brain region serves two main
functions: continuously maintain the roughly 24-hour cadence of the internal circadian clock and
be able to adapt to external light stimuli in order to synchronize the animal’s circadian rhythm to
the environment. Because of the SCN’s ability to maintain and shift this daily pattern, the brain
region is often referred to as the master pacemaker.
The endogenous clock characteristics were discovered when experiments were performed
on animals placed into constant light or constant dark environments (Halberg, 1959). Despite not
being able to detect the time of day based on presence or absence of light, the subjects still
maintained a roughly 24-hour cycle of rest and activity. This observation can be described as the
free running period which describes any situation where an animal’s endogenous rhythm can
cycle at its preferred rate without the influence of the environment. The SCN can endogenously
maintain this free-running period through transcription/translation loops of clock genes that
cyclically inhibit and stimulate each other during a period of roughly 24 hours (Vitaterna, et al.,
1994).
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The second characteristic is the SCN’s ability to adapt to the environment and shift the
phase, but not the duration, of the circadian rhythm. From its functionally relevant location, the
SCN receives input signals from the eye via the retinohypothalamic tract (RHT) whenever light
is detected. Light either advances or delays the phase depending whether the stimulus is
presented in the late or early night, respectively (Daan et al., 1976). Although not exclusive, light
is the most influential zeitgeber, German for “time giver,” that entrains the circadian clock. This
allows the animal to adjust its rhythm to seasonal changes in day length or feeding and activity
patterns.
This study is focused on the second function of the SCN: phase shifting. Upon
stimulation of the retina by light, axon terminals of the RHT release the neurotransmitter,
glutamate, onto SCN neurons. If this occurs during the subjective night time, the SCN will shift
in phase (Ebling, 1996). Through experimentation, it has been observed that providing glutamate
to SCN containing brain slices during the early subjective night will cause a delay of up to 3
hours in the circadian clock. In contrast, exposing the SCN to glutamate during the late
subjective night will advance the clock by up to 3 hours (Ding et al., 1994). The stimulus
necessary to produce glutamate, light, is present all day yet the SCN cannot shift its rhythm
during the day.
Our lab investigates the mechanisms controlling phase shifts and those that gate the
ability of the clock to shift. Light induced glutamate transmission to the SCN activates NMDA
receptors as seen in Figure 1. Activation of these receptors leads to calcium ion influx into the
post-synaptic SCN neuron and subsequent activation of nitric oxide synthase, which both
contribute to resetting the transcription and translation loop of clock genes (Ding et al., 1994).
These glutamate induced shifts depend on the presence of at least two extracellular proteins:
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mature brain-derived neurotrophic factor (mBDNF) and tissue-type plasminogen activator (tPA)
(Michel et al., 2006 & Mou et al., 2009).
tPA is a serine protease that converts inactive plasminogen into plasmin. It is most
commonly known for its role in intravascular thrombolysis; however, studies have shown it is
also an important part of the process of long-term potentiation in the hippocampus (Huang, Y. et
al., 1996 & Sonderegger, P. et al., 2014). Plasmin, a downstream protease, cleaves the “pro”
domain off of inactive proBDNF and converts it to its active form, mBDNF. The activated
growth factor then binds to the tyrosine kinase-B (TRK-B) receptor on the post-synaptic
membrane which, in conjunction with glutamate, initiates a phosphorylation cascade involving
multiple kinases that eventually activate clock gene transcription. It is known that BDNF is
rhythmically present in the SCN with higher levels at night than during the day (Liang et al.,
1998). In addition, tPA has also been shown to be rhythmically present in the SCN with higher
levels during the night (Mou et al., 2009 & Panda et al., 2002). Although studies have shown
these proteins are rhythmic in the SCN, the details of their subcellular localizations, which could
illuminate the gating mechanism for circadian phase shifting, are still unknown.
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Figure 1. Glutamate from the retinohypothalamic tract activates NMDA receptors in the SCN
every time light is detected; however, phase shifts can only occur when mBDNF can
concurrently activate the Trk B receptor. PAI
PAI-1
1 inhibits tPA which activates plasminogen into
plasmin which converts pro-BDNF
BDNF into m
m-BDNF.

Another influential protein is pplasminogen activator inhibitor-1 (PAI-1
1), which inhibits
the activity of tPA by binding to its catalytically active small chain (Vehar et al., 1984). This
means that the presence of PAI
PAI-1
1 indirectly inhibits the activation of proBDNF to mBDNF.
However, PAI-11 requires binding to another protein, vitronectin, in order to remain active and
inhibit glutamate induced phase shifting. Vitronectin is usually present in the fibrous network of
the extracellular matrix (ECM)
(ECM), which suggests that PAI-1
1 regulation of tPA likely occurs
extracellularly in proximity to the ECM (Preissner, K.T., 1991). Knowing the location of tPA at
different time points during the circ
circadian
adian rhythm could enhance our understanding of the
regulation of its activation or inactivation to influence phase shifting.
The purpose of this project is to determine the subcellular localization
ion of tPA and its
inhibitor, PAI-1, at different time points in the circadian rhythm over a 36-hour
hour period using an
immortalized cell culture of rat neurons from the SCN 2.2 line ((Earnest
Earnest et al., 1999 & Hurst et
al., 2002). Use of the cell culture allows us to determine whether the proteins of interest are
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within or associated with the cells versus attached to the ECM versus floating in the extracellular
space. The cell culture is preferable to testing mouse SCN brain slices because there is no
reliable technique for separating the three different compartments using brain slices.

METHODS AND MATERIALS
Immortalized SCN 2.2 cells were cultured and separated into three separate populations.
Each received a different treatment: one cohort was synchronized with fetal bovine serum (FBS),
another was synchronized with forskolin, and the third was given the control vehicle (Balsalobre,
1998 & Yagita et al., 2000). FBS synchronizes the eukaryotic cell culture because it contains
growth hormones to stimulate cell development (Franke, 2014). Forskolin activates adenylate
cyclase which resets the cell cycle and synchronizes all the cells to circadian time 10 (CT 10).
Circadian time 0-12 represents subjective day and CT 12-24 represents subjective night
For the first 36 hours immediately following treatment, samples were collected of the
media, cells, and ECM every three hours from each of the three cohorts. These were stored at
-80oC until protein assays could be completed. Two 36 hour time course experiments were
performed, one in June another in October of 2013.
Proteins were extracted from each of the three synchronization treatments of cell fraction
samples using trichloroacetic acid (TCA). In future experiments, proteins from the ECM fraction
will also be precipitated using TCA while proteins from the media fraction will be extracted
using ammonium (Link et al., 2009 & Nair, 1973).
Proteins from each of the 12 time points plus positive controls for tPA and PAI-1 were
loaded into 10% acrylamide SDS-PAGE gels and separated based on molecular weight using
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electrophoresis. Proteins in the gel were transferred to a polyvinylidene fluoride (PVDF)
membrane and washed in 1xPBST phosphate buffered saline with 20% Tween.
Proteins were visualized with immunoblotting. Prior to primary antibody application, a
5% milk/1xPBST solution was applied to the blot for one hour to block non-specific binding of
primary antibodies to non-target proteins on the membrane. The blot was exposed to primary
antibodies in 2% milk/1xPBST and incubated overnight at 4oC. The following day, secondary
antibodies were applied to the membrane for 90 minutes after 3x5 min washes in 1xPBST
according to the concentrations in Table 1. Chemiluminescent luminol/hydrogen peroxide was
applied for 3-5 minutes onto the membrane. This solution reacts to the horseradish peroxidase
conjugated to the secondary antibody to produce microscopic light radiation. After luminol
treatment, the blot was exposed to x-ray film for various periods from 5 seconds to 30 minutes.
The fixed and developed film was scanned into the computer and analyzed with ImageJ software
from the NIH. The pixel density of each protein band was quantified with ImageJ. Then
Microsoft Excel was used to calculate band comparisons. Pixel densities of tPA and PAI-1 were
divided by the corresponding lanes of α-tubulin load control. Values were normalized to CT 13.
Primary Antibody Protein of
interest

Optimized Primary
Concentration

Secondary
Antibody type

Optimized Secondary
Concentration

tPA
[H27B6] ab28374 Abcam

1:500

Mouse

1:1000

PAI-1
[H135] sc-8979 Santa Cruz

1:500

Rabbit

1:4000

α-tubulin (load control)
[B-5-1-2] sc-23948 Santa Cruz

1:500

Mouse

1:2000

Table 1. Proteins of interest and respective antibodies used to visualize them. Secondary
antibody concentration varied slightly for some Western blots.
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RESULTS
Preliminary results confirmed the presence of tPA and PAI
PAI-1
1 in the cell fraction of the
SCN 2.2 cells. The results also show potentially rhythmic expression in PAI-1
PAI following
forskolin and serum synchronization. Conversely, preliminary results sshow that tPA increases
steadily from onset of serum synchronization instead of being expressed rhythmically.
Figure 2 shows that PAI
PAI-1 appears to be rhythmically present
resent inside the cell fraction.
PAI-1’s potential rhythm begins
ins with high levels during early subjective night (CT 13) that
decrease until its lowest expression at early subjective day (CT 1). PAI-1 peaks again just before
the beginning of subjective night
night. However, during the second subjective night,
ight, PAI-1
PAI levels
appear to increase
rease rather than decrease. Therefore
Therefore, although expression appears to be rhythmic, it
is not fully clear from these data whether the rhythm in intracellular PAI-1
PAI expression is
circadian in nature. The PAI-11 positive control did not develop with immunochemiluminescence.

Figure 2. Relative abundance of PAI
PAI-1 inside the cell is shown throughout the 36-hour
36
time
course following forskolin treatment
treatment. There appears to be a rhythm in PAI-1 expression inside
the cell after forskolin synchronization. n=1
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The results from the FBS synchronized cells ((Figure 3) are somewhat consistent with
those from the forskolin synchronization. PAI-1
1 positive control confirms presence of PAI-1;
PAI
however, the PAI-1 positive
ive control has a different molecular weight than the PAI-1
PAI present in
the SCN due to possible glycosylation
glycosylation. PAI-1 expression in the SCN 2.2 cells again decreases
throughout the first subjective night
night, increases during the subjective day, and finally decreases
during
ng the second subjective night. This overall pattern is disrupted only by the data from CT 1,
which shows a higher expression
pression level than expected.. (The data for the second CT 22 was
discarded as an outlier because it was of 5.9 times higher than the 1st data point at CT 13).

PAI-1 inside the cell is shown throughout the 36-hour
36
time
Figure 3. Relative abundance of PAI
course after serum shock.. There may be a possible rhythm in PAI
PAI-1 expression inside the cell
after FBS synchronization that mostly accords with forskolin experiment. n=1
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In contrast to the two synchronized cohorts, the ppreliminary
reliminary results from the nonsynchronized cells shown in Figure
igure 4 indicate an arrhythmic pattern of PAI-1
1 expression. This
was expectedd because a synchroni
synchronizing
zing treatment is necessary to see a rhythm in protein
expression of those related to the circadian pacemaker (Balsalobre et al.,, 1998). Again, the final
time point was omitted because it was 4.7 times higher than the density of PAI
PAI-1
1 at CT 13.

Figure 4. Relative abundance of PAI
PAI-1 inside the cell is shown throughout the 36-hour
36
time
course after treatment with the vehicle control.. There does not appear to be any noticeable
rhythm of PAI-11 inside the SCN cells with the vehicle control. n=1
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Figure 5 shows the pattern of tPA expression in the SCN 2.2 cells following FBS
synchronization. There appears to be a steady increase throughout the 36 hour experiment. The
tPA positive control is clearly visible. As in the two previous experiments, the data from the final
time point was much higher than the other data points by a factor
actor of 29.5 so it was omitted.
omitted

ughout the 36-hour
36
time
Figure 5. Relative abundance of tPA inside the cell is shown throughout
course. tPA appears to increase over time; however, no circadian rhythms are apparent. n=1

DISCUSSION
These preliminary results (n=1 for each experiment) show that both tPA and PAI-1
PAI are
present inside the cell fraction of SCN2.2 cells throughout the circadian cycle. While speculative,
speculative
intracellular PAI-1 levels may peak during the early subjective night. Previous work in our lab
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has shown that total PAI-1 expression in brain slices, which includes all three subcellular
compartments, similarly peaks during the early night (Mou, 2010). Whether this rhythm is
actually in phase with the circadian clock will need to be determined by repeating each of these
experiments.
According to our model, PAI-1 inhibition should be greater during the subjective day
than during the subjective night. One mechanism through which this could occur would be if
extracellular PAI-1 levels are higher during the day than the night. Thus, higher intracellular
PAI-1 levels during the subjective night as tentatively shown here could be consistent with less
PAI-1 inhibition at night due to PAI-1 movement into the cell. However, it will be important to
determine the level of PAI-1 in the extracellular media and associated with the ECM to
determine whether this model is correct.
Western blot analysis for tPA shows an increase in intracellular tPA expression
throughout the 36 hour time course. This is not consistent with our model for the activation of
BDNF to gate photic phase shifting, and it is different from the pattern of expression our lab has
observed previously (Mou et al., 2009). Additional replicates may confirm this unexpected
expression pattern or show results that support previous data. However, it is possible that the
synchronization treatment decreases tPA to unnaturally low levels before it slowly increases to
acclimate to its new synchronization environment. This experiment should be repeated using
different synchronization techniques to see a clearer picture of the expression and localization of
tPA.
Several challenges arose with this project. One involved the need to use variable
secondary antibody concentrations due to the low amount of protein in each lane of the
acrylamide gel. Sonication was added to the TCA protein precipitation technique, and this
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allowed the protein pellet to be broken up into much smaller fragments for better
homogenization into the loading dye to be injected into the gel. This allowed us to use lower and
more consistent secondary antibody concentrations, which led to less non-specific binding. The
developed Western blots showed cleaner protein bands that were easier to analyze without nearly
as much background noise. This method improved the results for PAI-1 and α-tubulin, but tPA
still did not develop without excess background. In addition, both tPA and PAI-1 positive
controls were inconsistently present for the last few Western blots.
For analysis of potential circadian rhythms in protein expression, it is important to note
that the free-running period for SCN 2.2 cells is not exactly 24 hours but has been shown to be
closer to 22.5 hours (Balsalobre, 1998). This means that circadian time should be calculated
using an 11.25 hour day: 11.25 hour night rhythm instead of a 12 hour day: 12 hour night
rhythm. Although these results are graphed using a 24 hour cycle to be consistent with previous
experiments in our lab, measuring the length of daytime and nighttime with the shorter period
might be more appropriate in future studies.
Moving forward, we must conduct further experiments investigating PAI-1 and tPA in
the cell fraction of both 36 hour time courses. Next, the ECM and media fractions should be
studied to draw more conclusions about the temporal localization of tPA and PAI-1 in different
compartments. In the future, the cell culture time course could be extended to 48 hours because
SCN 2.2 cells can maintain circadian rhythms for up to three days past synchronization
(Balsalobre, 1998). This would allow us to improve the quality and accuracy of protein
measurements by having multiple replicates of the same circadian time. In addition, allowing the
cell culture at least 24 hours prior to initiating sampling could eliminate acute responses to the
treatments by allowing the cells to acclimate to the synchronization treatments. This is because it
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has been shown that certain clock genes have poor rhythmicity for 12-24 hours post
synchronization (Ramsey, 2014).
With more information on how the tPA proteolytic pathway affects the ability of the
clock to shift phase, we can answer questions that could lead to future drug discoveries to help
people with shift workers’ disorder, Alzheimer’s disease, jet lag, insomnia, metabolic disorders,
and obesity related to the SCN’s function as the master pacemaker (Taniyama et al., 2015,
Landry, 2014, & Eckel-Mahan, 2013). Moreover, tPA’s temporal location in the SCN and how it
relates to gating circadian clock phase resetting may yield a greater understanding of the
mechanisms behind the overarching phenomenon of metaplasticity. This is defined as the ability
for one stimulus to cause a permanent or semi-permanent change in synapses that allows or
prevents them from reacting to future stimuli (Abraham, 2008). This is relevant to other parts of
the brain such as the hippocampus, where there is evidence that metaplasticity describes the
function of gating whether the brain retains or forgets recent memories (Bramham et al., 2005,
Iver et al., 2014, & Deisseroth et al., 1995).
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